Literature DB >> 9699233

Bayesian optimal design in population models for haematologic data.

J L Palmer1, P Müller.   

Abstract

We introduce a population model to design optimal apheresis schedules to collect blood stem cells from cancer patients. Blood stem cells are collected prior to the patient undergoing high-dose chemoradiotherapy and are returned after this treatment to enable reconstitution of the white blood cell components. Maximizing the number of cells collected in as few apheresis as possible is desirable. We use a longitudinal data model with random effects to describe profiles of individual patients. A hierarchical prior model introduces common mean profiles for patients undergoing different treatments. We find the optimal apheresis schedule for a new patient by minimizing an expected loss over the posterior predictive distribution of the patient's predicted CD34 profile. We implement estimation of the model and solution of the optimal design problem by a simulation approach, which allows us to accommodate arbitrary shapes for the profiles and realistic loss functions that include relative penalties for the number of scheduled stem cell collections and for collecting fewer than a specified target quantity of total collected stem cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9699233     DOI: 10.1002/(sici)1097-0258(19980730)17:14<1613::aid-sim867>3.0.co;2-c

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  4 in total

1.  Impact of pharmacokinetic-pharmacodynamic model linearization on the accuracy of population information matrix and optimal design.

Authors:  Y Merlé; M Tod
Journal:  J Pharmacokinet Pharmacodyn       Date:  2001-08       Impact factor: 2.745

2.  Determination of an optimal dosage regimen using a Bayesian decision analysis of efficacy and adverse effect data.

Authors:  Gordon Graham; Suneel Gupta; Leon Aarons
Journal:  J Pharmacokinet Pharmacodyn       Date:  2002-02       Impact factor: 2.745

Review 3.  Facilitation of drug evaluation in children by population methods and modelling.

Authors:  Michel Tod; Vincent Jullien; Gérard Pons
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447

4.  Optimal experimental design for mathematical models of haematopoiesis.

Authors:  Luis Martinez Lomeli; Abdon Iniguez; Prasanthi Tata; Nilamani Jena; Zhong-Ying Liu; Richard Van Etten; Arthur D Lander; Babak Shahbaba; John S Lowengrub; Vladimir N Minin
Journal:  J R Soc Interface       Date:  2021-01-27       Impact factor: 4.118

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.